Eli Lilly

Lilly and Boehringer's Jardiance Racks Up Another Type 2 Diabetes Win
BioSpace
Wed, 12/7/22 - 11:40 pm
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
Jardiance
pediatri
Eli Lilly tightens access to diabetes drug, frustrating some people with obesity
Stat
Wed, 12/7/22 - 10:08 am
Eli Lilly
type 2 diabetes
obesity
Mounjaro
social media
Lilly gearing up for 'substantial expansion' of diabetes med manufacturing by 2025
Fierce Pharma
Tue, 12/6/22 - 09:00 pm
Eli Lilly
Mounjaro
diabetes
type 2 diabetes
obesity
drug manufacturing
This Week at FDA: FDA approves first FMT product, upcoming mpox guidance, and more
RAPS.org
Sun, 12/4/22 - 01:29 pm
FDA
regulatory
mpox
Ferring Pharmaceuticals
microbiome
COVID-19
Eli Lilly
Amgen to push latecomer obesity drug into midstage testing
Pharmaphorum
Sun, 12/4/22 - 01:26 pm
Amgen
Novo Nordisk
Eli Lilly
obesity
clinical trials
AMG 133
Lilly’s Donanemab Shines vs. Aduhelm in First Active Comparator Study
BioSpace
Thu, 12/1/22 - 07:10 pm
Eli Lilly
donanemab
clinical trials
Aduhelm
Biogen
Alzheimer's disease
Eli Lilly dumps Innovent's PD-1 after FDA rebuff, nixing high-profile Chinese cancer drug
Fierce Pharma
Thu, 12/1/22 - 07:03 pm
Eli Lilly
Innovent Biologics
Tyvyt
China
Lilly's Covid-19 mAb no longer authorized due to Omicron subvariants, FDA says
Endpoints
Wed, 11/30/22 - 08:04 pm
Eli Lilly
FDA
COVID-19
Omicron
bebtelovimab
monoclonal antibodies
Lilly backs $45M investment for mRNA cancer immunotherapy startup
Businesswire
Mon, 11/28/22 - 10:16 am
Strand Therapeutics
funding
Eli Lilly
rRNA
cancer
Biggest drug companies halted Twitter ad buys after Lilly insulin spoof
Endpoints
Mon, 11/21/22 - 06:38 pm
twitter
social media
pharma ads
Eli Lilly
Eli Lilly to double its manufacturing capacity for Mounjaro as it faces financial headwinds going into 2023 — report
Endpoints
Mon, 11/21/22 - 06:34 pm
Eli Lilly
Mounjaro
diabetes
type 2 diabetes
drug manufacturing
Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds
MedCity News
Sun, 11/20/22 - 12:37 pm
Acrivon Therapeutics
Eli Lilly
IPOs
Proteomics
cancer
oncology
Lilly wins FDA approval for second interchangeable insulin biosimilar
Endpoints
Thu, 11/17/22 - 11:27 pm
Eli Lilly
FDA
insulin
diabetes
biosimilars
Roche Failure Leaves Industry Reassessing Alzheimer's Space
BioSpace
Wed, 11/16/22 - 10:45 am
Roche
Alzheimer's disease
gantenerumab
Biogen
Cassava Sciences
Eli Lilly
Fake Eli Lilly Twitter account falsely claimed insulin 'free'
Indianapolis Star, IN
Fri, 11/11/22 - 10:50 am
Eli Lilly
social media
insulin
twitter
Elon Musk
Eli Lilly ordered to pay $177M to rival Teva in migraine patent fight
Fierce Pharma
Thu, 11/10/22 - 10:12 pm
Eli Lilly
legal
migraines
Ajovy
patents
Lilly’s new diabetes management platform to integrate Dexcom CGM
Medtech Dive
Wed, 11/9/22 - 10:44 am
Eli Lilly
diabetes
DexCom
Medtech
devices
Tempo
Early data hint at benefit for Amgen’s obesity drug
BioPharma Dive
Wed, 11/9/22 - 10:32 am
Amgen
obesity
Eli Lilly
Novo Nordisk
AMG 133
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Eli Lilly
Boehringer Ingelheim
chronic kideny disease
Jardiance
Farxiga
AstraZeneca
Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro
Xtalks
Thu, 11/3/22 - 07:25 pm
Eli Lilly
Mounjaro
Novo Nordisk
Ozempic
type 2 diabetes

Pages